Cargando…
Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
OBJECTIVES: To address whether the use of methotrexate (MTX) and biological disease-modifying anti-rheumatic drugs (bDMARDs) impacts bone structure and biomechanical properties in patients with psoriatic arthritis (PsA). METHODS: This is a cross-sectional study in PsA patients receiving no DMARDs, M...
Autores principales: | Simon, David, Kleyer, Arnd, Bayat, Sara, Tascilar, Koray, Kampylafka, Eleni, Meinderink, Timo, Schuster, Louis, Petrov, Ramona, Liphardt, Anna-Maria, Rech, Juergen, Schett, Georg, Hueber, Axel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607518/ https://www.ncbi.nlm.nih.gov/pubmed/31269973 http://dx.doi.org/10.1186/s13075-019-1938-3 |
Ejemplares similares
-
Secukinumab leads to shifts from stage-based towards response-based disease clusters—comparative data from very early and established psoriatic arthritis
por: Kampylafka, Eleni, et al.
Publicado: (2020) -
Similar Impact of Psoriatic Arthritis and Rheumatoid Arthritis on Objective and Subjective Parameters of Hand Function
por: Liphardt, Anna‐Maria, et al.
Publicado: (2020) -
Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study
por: Kampylafka, Eleni, et al.
Publicado: (2018) -
Accuracy and usability of a diagnostic decision support system in the diagnosis of three representative rheumatic diseases: a randomized controlled trial among medical students
por: Knitza, Johannes, et al.
Publicado: (2021) -
Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs
por: Vodencarevic, Asmir, et al.
Publicado: (2021)